Stabilised supersaturated solids of lipophilic drugs
Details for Australian Patent Application No. 2005221403 (hide)
International Classifications
Event Publications
28 September 2006 PCT application entered the National Phase
PCT publication WO2005/087199 Priority application(s): WO2005/087199
5 April 2007 Amendment Made
The nature of the amendment is: Amend the priority details from 14075714.8 10 Mar 2004 EP to 04075714.8 10 Mar 2004 EP 2005229161 Prana Biotechnology Limited The nature of the amendment is: Add co-inventor Kenche, Vijaya
1 October 2009 Alteration of Name
The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft
10 December 2009 Application Accepted
Published as AU-B-2005221403
7 January 2010 Corrigenda
Applications Accepted - Name Index Under the name Bayer Schering Pharma Aktiengesellschaft, Application No. 2005221403, under INID (54), correct the title to read Stabilised supersaturated solid solutions of steroidal drugs
8 April 2010 Standard Patent Sealed
4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005221402-Compositions comprising drospirenone molecularly dispersed
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser